A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

Published:2013-02 Issue:2 Volume:63 Page:189-197
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Parker Christopher C.,Pascoe Sarah,Chodacki Aleš,O'Sullivan Joe M.,Germá Josep R.,O’Bryan-Tear Charles Gillies,Haider Trond,Hoskin Peter

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone;Lange;Cancer Metastasis Rev,1999

2. Metastasis to bone: causes, consequences, and therapeutic opportunities;Mundy;Nat Rev Cancer,2002

3. Bone health and prostate cancer;Saylor;Prostate Cancer Prostatic Dis,2010

4. Bisphosphonates in prostate carcinoma;Adami;Cancer,1997

5. Systemic radiopharmaceutical therapy of painful osteoblastic metastases;Silberstein;Semin Radiat Oncol,2000

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to 223RaCl2 or 177Lu-iPSMA treatment in bone metastases due to castration-resistant prostate cancer as a function of absorbed dose;Radiation Physics and Chemistry;2024-09

2. From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer;Cancers;2024-08-31

3. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

4. Prostate Cancer Theranostics With 177Lu-PSMA;Seminars in Nuclear Medicine;2024-07

5. Current state of theranostics in metastatic castrate‐resistant prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-04-17